Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trialChigusa Morizane, Junji Furuse, Makoto Ueno et al.|Annals of Oncology|2019Cited by 333
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)Kiyoshi Hasegawa, Ryosuke Tateishi, Nobuyuki Takemura et al.|Hepatology Research|2023Cited by 267